


| Ingredients | Product Name | Formulation | Report Category | Report Date |
| Microolanzapine | Zyprexa ZyDis Dispersible Tablets 5 Milligrams (Olanzapine Microparticles) | Oral Disintegrating Tablet | Supply Shortage | 2026-02-13 |
| Microolanzapine | Zyprexa Zydis Extended-Release Tablets 10 milligrams (olanzapine) | Oral Disintegrating Tablet | Supply Shortage | 2026-02-13 |
| Bacillus licheniformis, Calcium Pantothenate | Jang Eiderock Capsule | Hard Capsule, Powder | Supply Discontinuation | 2026-02-12 |
| Bemiparin Sodium | Zyber 2500 IU Anti-Xa/0.2 mL (Vemiparin Sodium) | Solution for Injection | Supply Discontinuation | 2026-02-10 |
| Bemiparin Sodium | Zyber Injection 3500 IU AntiXa/0.2 mL (Vemiparin Sodium) | Solution for Injection | Supply Discontinuation | 2026-02-10 |
| Pimozide | Myeongin Pimozide Tablets 4 milligrams | Najeong | Supply Discontinuation | 2026-02-04 |
| Nimodipine | Samjin Nimodipine Injection 10 Milligram (Export Name: Moditoplinjection) | Solution for Injection | Supply Shortage | 2026-02-03 |
| Cisplatin | Unistin Injection 0.5mg/ml (Cisplatin) (Export Name: Newplatin Inj. 0.5mg/ml, Cytosplat Inj. 0.5mg/ml, Nextin Inj. 0.5mg/ml, KU Cisplatin Inj. 0.5mg/ml | Solution for Injection | Supply Discontinuation | 2026-02-03 |
| Isosorbide Dinitrate Sustained-Release Granules | Bukwang Isomac Sustained-Release Capsules (Isosorbide Dinitrate Sustained-Release Granules) | Sustained-Release Capsule, Pellet | Supply Discontinuation | 2026-02-02 |
| Polysaccharide Iron Complex | Hemonia Capsule (Polysaccharide Iron Complex) | Hard Capsule, Powder | Supply Discontinuation | 2026-01-30 |
| Fluvastatin Sodium | Rescol XL Extended-Release Tablets (Fluvastatin Sodium) | Extended-Release Film-Coated Tablets | Supply Discontinuation | 2026-01-29 |
| Bacillus licheniformis, Calcium Pantothenate | Biscanbisan | Powder | Supply Discontinuation | 2026-01-28 |
| Talazoparib Tosylate | Talzena Capsule 1 Milligram (Talazoparib Tosylate) | Hard Capsule, Powder | Supply Discontinuation | 2026-01-28 |
| Haloperidol Decanoate | Haloperidol Decanoate Injection (Haloperidol Decanoate) | Solution for Injection | Supply Shortage | 2026-01-28 |
| Human Papillomavirus-16 L1 (Host: Trichoplusia ni Hi-5 Rix4446, Vector: rBaculo4449), Human Papillomavirus-18 L1 (Host: Trichoplusia ni Hi-5 Rix4446, Vector: rBaculo4450) | Suvarix Prefilled Syringe [Human Papillomavirus Vaccine (Recombinant)] | Suspension for Injection | Supply Discontinuation | 2026-01-23 |
| Sodium Bicarbonate | Daewon Sodium Bicarbonate Injection (8.4%) | Solution for Injection | Supply Shortage | 2026-01-22 |
| Ketorolac Tromethamine | Acuveil Eye Drops 0.45% (Ketorolac Tromethamine) (Single-Use) | Eye Drops | Supply Shortage | 2026-01-21 |
| Vinblastine Sulfate | Vinblastine Sulfate Injection | Freeze-Dried Powder for Solution Injection | Supply Discontinuation | 2026-01-15 |
| Dilazep Hydrochloride Hydrate | Bukwang Comelian Tablets 50 milligrams (Dilazep Hydrochloride Hydrate) | Film-coated Tablet | Supply Discontinuation | 2026-01-15 |
| Dacarbazine | DTIC Injection 200 Milligrams (Dacarbazine) (Export Name: DTIC-VHB for injection, Duticin for injection) | Freeze-Dried Powder for Solution Injection | Supply Discontinuation | 2026-01-15 |
| Mecuitazine | Primaran Tablets (Mequitazine) | Najeong | Supply Discontinuation | 2026-01-15 |
| Dacarbazine | DTIC Injection (Dacarbazine) (Export Name: DTIC-VHB for injection 100mg) | Freeze-Dried Powder for Solution Injection | Supply Discontinuation | 2026-01-15 |
| Deferasirox | Exzide Film-Coated Tablets 180 milligrams (Deferasirox) | Film-coated Tablet | Supply Shortage | 2026-01-14 |
| Dexketoprofen Trometamol | Keral Injection (Dexketoprofen Trometamol) | Solution for Injection | Supply Discontinuation | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 20 milligrams (oxycodone hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 40 milligrams (oxycodone hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 80mg (Oxycodone Hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 10mg (Oxycodone Hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Nalbuphine Hydrochloride | Nalbuphine Hydrochloride Injection 10 Milligrams | Solution for Injection | Supply Discontinuation | 2026-01-05 |
| Nimodipine | Cerebonal Tablets (Nimodipine) | Film-coated Tablet | Supply Discontinuation | 2026-01-05 |
| Active ingredients |
| Date of last message | Type of reason | AM designation | |
| Trimipramine mesylate | Change notification | 13.02.2026 | Other | Trimipramine – 1 A Pharma 40 mg/ml oral drops, solution | |
| Alprazolam | Change notification | 13.02.2026 | Other | Alprazolam – 1 A Pharma 0.5 mg tablets | |
| Chlortalidone | Change notification | 13.02.2026 | Other | Chlortalidone HEXAL 12.5 mg tablets | |
| Dexketoprofen trometamol | Change notification | 13.02.2026 | Production problem | Sympal inject 50 mg injection/infusion solution | |
| Anastrozole | Change notification | 13.02.2026 | Production problem | AnastroPUREN 1 mg film-coated tablets | |
| Isoniazid | Change notification | 13.02.2026 | Other | Isozid 100 mg | |
| Potassium iodide; levothyroxine sodium | Change notification | 13.02.2026 | Other | Thyronajod 75 Henning | |
| Potassium iodide; levothyroxine sodium | Initial report | 13.02.2026 | Other | Thyronajod 100 Henning | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Initial report | 12.02.2026 | Other | ATORVASTATIN BASICS 60 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 12.02.2026 | Other | ATORVASTATIN BASICS 30 mg film-coated tablets | |
| Ciprofloxacin hydrochloride monohydrate | Initial report | 12.02.2026 | Other | CIPRO BASICS 500 mg film-coated tablets | |
| Esomeprazole hemimagnesium | Change notification | 12.02.2026 | Production problem | ESOMEPRAZOLE BASICS 20 mg gastro-resistant hard capsules | |
| Candesartan cilexetil | Change notification | 12.02.2026 | Other | CANDESARTAN BASICS 4 mg tablets | |
| Candesartan cilexetil | Change notification | 12.02.2026 | Other | CANDESARTAN BASICS 8 mg tablets | |
| Candesartan cilexetil | Change notification | 12.02.2026 | Other | CANDESARTAN BASICS 32 mg tablets | |
| Ciprofloxacin hydrochloride monohydrate | Change notification | 12.02.2026 | Other | CIPRO BASICS 250 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Initial report | 12.02.2026 | Other | ATORVASTATIN BASICS 40 mg film-coated tablets | |
| Esomeprazole hemimagnesium | Change notification | 12.02.2026 | Production problem | ESOMEPRAZOLE BASICS 40 mg gastro-resistant hard capsules | |
| Tacrolimus monohydrate | Initial report | 12.02.2026 | Production problem | Tacpan 5 mg hard capsules | |
| Zidovudine | Initial report | 12.02.2026 | Production problem | Zidovudine Aurobindo 250 mg hard capsules | |
| Ondansetron hydrochloride dihydrate | Initial report | 12.02.2026 | Production problem | Ondansetron Aurobindo 4 mg film-coated tablets | |
| Escitalopram oxalate | Initial report | 12.02.2026 | Other | Escitalopram Aurobindo 10 mg film-coated tablets | |
| Duloxetine hydrochloride | Initial report | 12.02.2026 | Other | Duloxetine Aurobindo 60 mg gastro-resistant hard capsules | |
| Venlafaxine hydrochloride | Initial report | 12.02.2026 | Production problem | Venlafaxine Aurobindo 75 mg hard capsule, delayed release | |
| Dutasteride; tamsulosin hydrochloride | Initial report | 12.02.2026 | Production problem | Dutasteride/tamsulosin PUREN 0.5 mg/0.4 mg hard capsules | |
| Deferoxamine mesylate | Initial report | 12.02.2026 | Production problem | Deferoxamine mesylate 2 g powder for solution for injection or infusion | |
| Amiodarone hydrochloride | Initial report | 12.02.2026 | Production problem | Amiodarone Aurobindo 200 mg tablets | |
| Paliperidone palmitate | Change notification | 12.02.2026 | Other | Paliperidone AL 25 mg depot injection suspension in a pre-filled syringe | |
| Dexamethasone acetate (Ph.Eur.); lidocaine hydrochloride monohydrate | Initial report | 11.02.2026 | Production problem | Supertendin 5 | |
| Dexamethasone acetate (Ph.Eur.); lidocaine hydrochloride monohydrate | Initial report | 11.02.2026 | Production problem | Supertendin 10 | |
| Lidocaine hydrochloride monohydrate | Change notification | 10.02.2026 | Other | Xylocaine Gel 2% | |
| Estriol | Initial report | 10.02.2026 | Other | Ovestin 1 mg tablets | |
| Sertraline hydrochloride | Change notification | 10.02.2026 | Production problem | Sertraline-neuraxpharm 200 mg film-coated tablets | |
| Sertraline hydrochloride | Change notification | 10.02.2026 | Production problem | Sertraline-neuraxpharm 150 mg film-coated tablets | |
| Levetiracetam | Change notification | 10.02.2026 | Production problem | Levetiracetam Holsten 750 mg film-coated tablets | |
| Human insulin ((with manufacturing details)) | Initial report | 09.02.2026 | Other | Huminsulin Basal (NPH) 100 100 IU/ml injection suspension in vial | |
| Thioctic acid trometamol salt (1:1) | Change notification | 09.02.2026 | Other | Thioctacid 600 T | |
| Prednisolone acetate | Change notification | 09.02.2026 | Production problem | Prednifluid 10 mg/ml eye drop suspension | |
| Terazosin hydrochloride dihydrate | Change notification | 09.02.2026 | Other | Heitrin 5 mg | |
| Terazosin hydrochloride dihydrate | Change notification | 09.02.2026 | Other | Heitrin 1mg | |
| Terazosin hydrochloride dihydrate | Change notification | 09.02.2026 | Other | Heitrin 2 mg | |
| Dapson | Initial report | 09.02.2026 | Other | Dapsone Zentiva 50 mg tablets | |
| Mometasone furoate (Ph.Eur.) | Change notification | 09.02.2026 | Production problem | Momecutan solution | |
| Isoniazid | Change notification | 09.02.2026 | Other | Isozid 50 mg | |
| Rifampicin sodium | Change notification | 09.02.2026 | Other | Eremfat i.v. 600mg |
| Active ingredients | Status | Update | Specialty |
| amoxicillin sodium, potassium (clavulanate) | Stock shortage | 13/02/2026 | Levmentin 1 g/200 mg, powder for solution for injection/infusion (IV) |
| Human rabies immunoglobulin | Marketing discontinuation | 13/02/2026 | Imogam Rage 150 IU/mL, injectable solution |
| tropatépine (hydrochloride) | Supply tension | 12/02/2026 | Lepticur 10 mg, tablet |
| aztreonam | Stock shortage | 11/02/2026 | Azactam 1 g, powder and solution for parenteral use |
| isoniazid, pyrazinamid, rifampicin | Supply tension | 11/02/2026 | Rifater, coated tablet |
| epirubicin (hydrochloride) | Stock shortage | 11/02/2026 | Farmorubicin 10 mg, powder for solution for infusion |
| acetylcholine chloride | Stock shortage | 11/02/2026 | Miochole 20 mg, powder and solvent for intraocular solution |
| 131I CIS Bio International 7.5 to 15 MBq/mL solution for injection | Stock shortage | 11/02/2026 | Iodinated norcholesterol |
| lenalidomide | Supply tension | 10/02/2026 | Lenalidomide Mylan, capsule |
| selinexor | Return to availability | 10/02/2026 | Nexpovio 20 mg, film-coated tablet |
| ethyl loflazepate | Stock shortage | 09/02/2026 | Victan 2 mg, film-coated tablet |
| methylphenidate (hydrochloride) | Supply tension | 09/02/2026 | Viatris LP Methylphenidate Extended-Release Tablet |
| lithium (carbonate) | Stock shortage | 09/02/2026 | Teralithe 250 mg, breakable tablet |
| fluorouracil | Supply tension | 09/02/2026 | Fluorouracil Pfizer 50 mg/mL, solution for dilution for infusion – 20 mL and 100 mL vials |
| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| ibandronate sodium | Tablet, film coated | 56.25 mg | Anticipated | Available | Manufacturing | 13/02/2026 |
| methylphenidate hydrochloride | Tablet, modified release | 27 mg | Current | Limited Availability | Manufacturing | 13/02/2026 |
| calcitonin salmon | Injection, solution | 100 IU/mL | Anticipated | Available | Unexpected increase in consumer demand | 13/02/2026 |
| pentetic acid | Injection, powder for | 5 mg | Current | Unavailable | Manufacturing | 13/02/2026 |
| medronic acid | Injection, powder for | 10 mg | Current | Unavailable | Manufacturing | 13/02/2026 |
| sodium valproate | Tablet, uncoated | 100 mg | Anticipated | Available | Manufacturing | 13/02/2026 |
| olanzapine | Tablet, orally disintegrating | 10 mg | Current | Limited Availability | Manufacturing | 13/02/2026 |
| Rabies virus | Injection, powder for | 2.5 IU | Anticipated | Available | Manufacturing | 13/02/2026 |
| lacosamide | Tablet, film coated | 50 mg | Anticipated | Available | Manufacturing | 13/02/2026 |
| deferasirox | Tablet, film coated | 180 mg | Current | Limited Availability | Manufacturing | 13/02/2026 |
| progesterone | Pessary | 400 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 13/02/2026 |
| methylphenidate hydrochloride | Capsule, hard | 60 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 13/02/2026 |
| azacitidine | Tablet, film coated | 300 mg | Anticipated | Available | Manufacturing | 13/02/2026 |
| olipudase alfa | Injection, powder for | 4 mg | Anticipated | Available | Manufacturing | 13/02/2026 |
| phenytoin sodium | Injection, solution | 250 mg | Resolved | Available | Manufacturing | 13/02/2026 |
| methylphenidate hydrochloride | Tablet, modified release | 18 mg | Current | Limited Availability | Manufacturing | 13/02/2026 |
| methylphenidate hydrochloride | Tablet, modified release | 36 mg | Current | Limited Availability | Manufacturing | 13/02/2026 |
| methylphenidate hydrochloride | Tablet, modified release | 54 mg | Current | Limited Availability | Manufacturing | 13/02/2026 |
| sumatriptan succinate | Tablet, film coated | 69.99 mg | Current | Unavailable | Manufacturing | 12/02/2026 |
| propofol | Injection, emulsion | 10 g/L | Anticipated | Available | Commercial Changes / Commercial viability | 12/02/2026 |
| ropivacaine hydrochloride | Injection, solution | 400 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 12/02/2026 |
| barium sulfate | Suspension, powder for | 98.453 % w/w | Current | Emergency Supply Only | Commercial Changes / Commercial viability | 12/02/2026 |
| ibuprofen | Injection, solution | 5 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 12/02/2026 |
| hydrochlorothiazide~olmesartan medoxomil | Tablet | 12.5 mg~40 mg | Current | Unavailable | Manufacturing | 12/02/2026 |
| dabigatran etexilate mesilate | Capsule, hard | 172.95 mg | Current | Unavailable | Manufacturing | 12/02/2026 |
| sildenafil citrate | Tablet, film coated | 70.24 mg | Current | Unavailable | Commercial Changes / Commercial viability | 12/02/2026 |
| sildenafil citrate | Tablet, film coated | 140.48 mg | Current | Limited Availability | Manufacturing | 12/02/2026 |
| ifosfamide | Injection, powder for | 2 g | Anticipated | Available | Manufacturing | 12/02/2026 |
| ropivacaine hydrochloride | Injection, solution | 7.5 mg/mL | Resolved | Available | Manufacturing | 12/02/2026 |
| reboxetine mesilate | Tablet, uncoated | 5.224 mg | Resolved | Available | Commercial Changes / Commercial viability | 12/02/2026 |
| cyclophosphamide monohydrate | Injection, powder for | 2.138 g | Anticipated | Available | Manufacturing | 12/02/2026 |
| gabapentin | Capsule, hard | 400 mg | Current | Unavailable | Manufacturing | 11/02/2026 |
| clozapine | Oral Liquid, suspension | 50 mg/mL | Current | Unavailable | Manufacturing | 11/02/2026 |
| omeprazole | Capsule, enteric | 20 mg | Resolved | Available | Manufacturing | 11/02/2026 |
| valsartan~hydrochlorothiazide | Tablet, film coated | 160 mg~12.5 mg | Current | Limited Availability | Manufacturing | 11/02/2026 |
| levetiracetam | Solution | 100 mg/mL | Current | Limited Availability | Manufacturing | 11/02/2026 |
| moxonidine | Tablet, film coated | 400 microgram | Current | Unavailable | Manufacturing | 11/02/2026 |
| ondansetron | Tablet, orally disintegrating | 4 mg | Current | Limited Availability | Manufacturing | 11/02/2026 |
| ezetimibe~simvastatin | Tablet | 10 mg~20 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 11/02/2026 |
| sildenafil citrate | Tablet, film coated | 140.48 mg | Current | Limited Availability | Manufacturing | 11/02/2026 |
| metoprolol succinate | Tablet, modified release | 23.75 mg | Resolved | Available | Unexpected increase in consumer demand | 11/02/2026 |
| dorzolamide hydrochloride | Eye Drops, solution | 22.26 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 11/02/2026 |
| desferrioxamine mesilate | Injection, powder for | 2 g | Resolved | Available | Manufacturing | 11/02/2026 |
| lamotrigine | Tablet, dispersible | 100 mg | Resolved | Available | Manufacturing | 11/02/2026 |
| betiatide | Injection, powder for | 1 mg | Current | Unavailable | Manufacturing | 10/02/2026 |
| cyproterone acetate | Tablet, uncoated | 50 mg | Current | Limited Availability | Manufacturing | 10/02/2026 |
| acetylcysteine | Injection, concentrated | 2 g | Resolved | Available | Manufacturing | 10/02/2026 |
| midazolam | Injection, solution | 50 mg | Current | Unavailable | Manufacturing | 10/02/2026 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Current | Unavailable | Commercial Changes / Commercial viability | 10/02/2026 |
| prednisolone acetate~phenylephrine hydrochloride | Eye Drops, suspension | 10 mg/mL~1.2 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 10/02/2026 |
| levonorgestrel~ethinylestradiol | Tablet, uncoated | 150 microgram~30 microgram | Current | Unavailable | Manufacturing | 10/02/2026 |
| elotuzumab | Injection, powder for | 340 mg | Current | Limited Availability | Manufacturing | 10/02/2026 |
| moxonidine | Tablet, film coated | 200 microgram | Current | Limited Availability | Manufacturing | 10/02/2026 |
| doxepin hydrochloride | Capsule, hard | 11.3 mg | Current | Unavailable | Manufacturing | 10/02/2026 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 10/02/2026 |
| fenofibrate | Tablet | 48 mg | Discontinued | Unavailable | Manufacturing | 10/02/2026 |
| daptomycin | Injection, powder for | 500 mg | Resolved | Available | Manufacturing | 10/02/2026 |
| daptomycin | Inhalation, powder for | 350 mg | Resolved | Available | Manufacturing | 10/02/2026 |
| stannous chloride dihydrate | Injection, powder for | 19.2 microgram/mL | Current | Unavailable | Manufacturing | 10/02/2026 |
| carbidopa monohydrate~levodopa | Tablet, uncoated | 26.9 mg~100 mg | Current | Limited Availability | Manufacturing | 10/02/2026 |
| cabergoline | Tablet, uncoated | 1 mg | Anticipated | Available | Manufacturing | 10/02/2026 |
| flunitrazepam | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 10/02/2026 |
| simvastatin | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 10/02/2026 |
| prazosin hydrochloride | Tablet, uncoated | 5.476 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 9/02/2026 |
| finasteride | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 9/02/2026 |
| amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 13.88 mg~86.751 mg | Current | Limited Availability | Manufacturing | 9/02/2026 |
| ezetimibe~simvastatin | Tablet | 10 mg~80 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 9/02/2026 |
| topotecan hydrochloride | Injection, concentrated | 4.346 mg | Current | Limited Availability | Unexpected increase in consumer demand | 9/02/2026 |
| sunitinib | Capsule | 25 mg | Anticipated | Available | Manufacturing | 9/02/2026 |
| agomelatinecitric acid | Tablet, film coated | 44.739 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 9/02/2026 |
| valsartan~sacubitril | Tablet, film coated | 51.4 mg~48.6 mg | Current | Unavailable | Manufacturing | 9/02/2026 |
| betahistine dihydrochloride | Tablet | 16 mg | Current | Limited Availability | Manufacturing | 9/02/2026 |
| varenicline tartrate | Tablet, film coated | 1.71 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 9/02/2026 |
| labetalol hydrochloride | Tablet, film coated | 200 mg | Current | Limited Availability | Manufacturing | 9/02/2026 |
| doxepin hydrochloride | Capsule, hard | 28.25 mg | Current | Unavailable | Manufacturing | 9/02/2026 |
| atovaquone~proguanil hydrochloride | Tablet, film coated | 62.5 mg~25 mg | Resolved | Available | Unexpected increase in consumer demand | 9/02/2026 |
February 10, 2026
February 12, 2026
February 11, 2026
February 10, 2026
February 09, 2026

